Contribution of apolipoprotein(a) size, pentanucleotide TTTTA repeat and C/T(+93) polymorphisms of the apo(a) gene to regulation of lipoprotein(a) plasma levels in a population of young European Caucasians

Atherosclerosis

Volumn 147, Issue 1, 1999, Pages 17-24

  Valenti, Kita ^a   Aveynier, Eveline ^a   Leauté, Stéphanie ^b   Laporte, François ^a   Hadjian, Arthur J ^a  

^a GRENOBLE UNIVERSITY HOSPITAL   (France)

^b UNIVERSITY HOSPITAL OF CLERMONT FERRAND   (France)

Author keywords

Apo(a) allele; Apo(a) isoform; Apo(a) polymorphism; Kringle 4; Lipoprotein(a)

Indexed keywords

APOLIPOPROTEIN A; DNA; LIPOPROTEIN A; NUCLEOTIDE;

ADULT; ALLELE; ARTICLE; CAUCASIAN; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; HUMAN EXPERIMENT; KRINGLE DOMAIN; MALE; NORMAL HUMAN; NUCLEOTIDE REPEAT; PHENOTYPE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL;

ADOLESCENT; ADULT; ALLELES; APOLIPOPROTEINS; APOPROTEIN(A); ENZYME-LINKED IMMUNOSORBENT ASSAY; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HUMANS; LIPOPROTEIN(A); MALE; MICROSATELLITE REPEATS; PHENOTYPE; POLYMORPHISM, GENETIC; PROTEIN ISOFORMS;

EID: 0032846602     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0021-9150(99)00137-9     Document Type: Article

References (32)

1. Berg K. Lp(a) lipoprotein: an overview. Chem Phys Lipids. 67-68:1994;9-16.
2. Scanu A.M., Edelstein C. Kringle-dependent structural and functional polymorphism of apolipoprotein(a). Biochim Biophys Acta. 1256:1995;1-12.
3. Dahlén G.H. Lp(a) lipoprotein in cardiovascular disease. Atherosclerosis. 108:1994;111-126.
4. Sandholzer C., Saha N., Kark J.D., Rees A., Jaross W., Dieplinger H., Hoppichler F., Boerwinckle E., Utermann G. Apo(a) isoforms predict risk for coronary heart disease. Arterioscler Thromb. 12:1992;1214-1226.
5. Jürgens G., Taddei-Peters W.C., Költringer P., Petek W., Chen Q., Greilberger J., Macomber P.F., Butman B.T., Stead A.G., Ransom J.H. Lipoprotein(a) serum concentration and apolipoprotein(a) phenotype correlate with severity and presence of ischemic cerebrovascular disease. Stroke. 26:1995;1841-1848.
6. Kraft H.G., Lingenhel A., Köchl S., Hoppichhler F., Kronenberg F., Abe A., Mühlberger V., Schnönitzer D., Utermann G. Apolipoprotein(a) kringle IV repeat number predicts risk for coronary heart disease. Arterioscler Thromb Vasc Biol. 16:1996;713-719.
7. Hervio L., Girard-Globa A., Durlach V., Anglés-Cano E. The antifibrinolytic effect of lipoprotein(a) in heterozygous subjects is modulated by the relative concentration of each of the apolipoprotein(a) isoforms and their affinity for fibrin. Eur J Clin Invest. 26:1996;411-417.
8. Chapman J.M., Huby T., Nigon F., Thillet J. Lipoprotein (a): implication in atherothrombosis. Atherosclerosis. 110:1994;S69-S75.
9. Grainger D.J., Kemp B.R., Mestcalfe J.C., Liu A.C., Lawn R.M., Williams N.R., Grace A.A., Schofield P.M., Chauhan A. The serum concentration of active transforming growth factor-β is severely depressed in advanced atherosclerosis. Nat Med. 1:1995;74-79.
10. Utermann G., Menzel H.J., Kraft H.G., Duba H.C., Kemmler H.G., Seitz C. Lp(a) glycoprotein phenotypes: inheritance and relation to Lp(a) lipoprotein concentration in plasma. J Clin Invest. 80:1987;458-465.
11. Lackner C., Boerwinkle E., Leffert C.C., Rahming T., Hobbs H.H. Molecular basis of apolipoprotein(a) isoform size heterogeneity as revealed by pulse-field gel electrophoresis. J Clin Invest. 87:1991;2153-2161.
12. Boerwinkle E., Leffert C.C., Lin J., Lackner C., Chiesa G., Hobbs H.H. Apolipoprotein(a) gene accounts for greater than 90% of the variation in plasma lipoprotein(a) concentrations. J Clin Invest. 90:1992;52-60.
13. Perombelon Y.F.N., Soutar A.K., Knight B.L. Variation in lipoprotein(a) concentration associated with different apolipoprotein(a) alleles. J Clin Invest. 93:1994;1481-1492.
14. Brunner C., Lobentanz E.M., Pethö-Schramm A., Ernst A., Kang C., Dieplinger H., Müller H.J., Utermann G. The number of identical kringle IV repeats in apolipoprotein(a) affects its processing and secretion by HepG2 cells. J Biol Chem. 271:1996;32403-32410.
15. Wade D.P., Clarke J.G., Lindahl G.E., Liu A.C., Zysow B.R., Meer K., Schwartz K., Lawn R.M. 5′ control regions of the apolipoprotein(a) gene and members of the related gene family. Proc Natl Acad Sci USA. 90:1993;1369-1373.
16. Suszuki K., Kuriyama M., Saito T., Ichinose A. Plasma lipoprotein(a) level and expression of the apolipoprotein(a) gene are dependent on the nucleotide polymorphisms in its 5′-flanking region. J Clin Invest. 99:1997;1361-1366.
17. Puckey L.H., Lawn R.M., Knight B.L. Polymorphisms in the apolipoprotein(a) gene and their relationship to allele size and plasma lipoprotein(a) concentration. Hum Mol Genet. 6:1997;1099-1107.
18. Mooser V., Mancini F.P., Bopp S., Pethö-Schramm A., Guerra R., Boerwinkle E., Müller H.J., Hobbs H.H. Sequence polymorphisms in the apo(a) gene associated with specific levels of Lp(a) in plasma. Hum Mol Genet. 4:1995;173-181.
19. Trommsdorff M., Köchl S., Lingenhel A., Kronenberg F., Delport R., Vermaak H., Lemming L., Klausen I.C., Faergeman O., Utermann G., Kraft H.G. A pentanucleotide repeat polymorphism in the 5′ control region of the apolipoprotein(a) gene is associated with lipoprotein(a) plasma concentrations in Caucasians. J Clin Invest. 96:1995;150-157.
20. Zyslow B.R., Lindahl G.E., Wade D.P., Knight B.L., Lawn R.M. C/T polymorphism in the 5′ untranslated region of the apolipoprotein(a) gene introduces an upstream ATG and reduces in vitro translation. Arterioscler Thromb Vasc Biol. 15:1995;58-64.
21. Sandholzer C., Hallman D.M., Saha N., Sigurdsson G., Lackner C., Császár A., Boerwinkle E., Utermann G. Effects of the apolipoprotein(a) size polymorphism on the lipoprotein(a) concentration in 7 ethnic groups. Hum Genet. 86:1991;607-614.
22. Helmhold M., Bigge J., Muche R., Mainoo J., Thiery J., Seidel D., Armstrong V.W. Contribution of the apo(a) phenotype to plasma Lp(a) concentrations shows considerable ethnic variation. J Lipid Res. 32:1991;1919-1928.
23. Gaw A., Boerwinkle E., Cohen J.C., Hobbs H.H. Comparative analysis of the apo(a) gene, apo(a) glycoprotein, and plasma concentration of Lp(a) in three ethnic groups. J Clin Invest. 93:1994;2526-2534.
24. Kraft H.G., Lingenhel A., Pang R.W.C., Delport R., Trommsdorff M., Vermaak H., Janus E.D., Utermann G. Frequency distributions of apolipoprotein(a) Kringle IV repeat alleles and their effects on lipoprotein(a) levels in Caucasian, Asian, and African populations: the distribution of null alleles is non-random. Eur J Hum Genet. 4:1996;74-87.
25. Marcovina S.M., Albers J.J., Wijsman E., Zhang Z., Chapman N.H., Kennedy H. Differences in Lp(a) concentrations and apo(a) polymorphs between black and white Americans. J Lipid Res. 37:1996;2569-2585.
26. Geroldi D., Bellotti V., Buscaglia P., Bonetti G., Gazzaruso C., Caprioli A., Fratino P. Characterization of apo(a) polymorphism by a modified immunoblotting technique in an Italian population sample. Clin Chim Acta. 221:1993;159-169.
27. Kraft H.G., Windengger M., Menzel H.J., Utermann G. Significant impact of the +93 CIT polymorphism in the apolipoprotein(a) gene on Lp(a) concentrations in Africans but not in Caucasians: confounding effect of linkage disequilibrium. Hum Mol Genet. 7:1998;257-264.
28. Valenti K., Aveynier E., Laporte F., Hadjian A.J. Evaluation of the genotyping and phenotyping approaches in the investigation of apolipoprotein(a) size polymorphism. Clin Chim Acta. 263:1997;249-260.
29. Lackner C., Cohen J.C., Hobbs H.H. Molecular definition of the extreme size polymorphism in apolipoprotein(a). Hum Mol Genet. 2:1993;933-940.
30. Fortmann S.P., Marcovina S.M. Lipoprotein(a), a clinically elusive lipoprotein particle. Circulation. 95:1997;295-296.
31. Steinmetz J., Tarallo P., Fournier B., Jaid M., Caces E.R., Vol S., Tichet J., Siest G. Valeurs de référence de la lipoprotéine(a) dans une population française. Presse Medicale. 23:1994;1695-1699.
32. White A.L., Guerra B., Lanford R.E. Influence of allelic variation on apolipoprotein(a) folding in the endoplasmic reticulum. J Biol Chem. 272:1997;5048-5055.